Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
Holding NMLSF?
Track your performance easily
NMLSF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.09
Previous CloseN/A
Volume8.00K
Average Volume (3M)4.68K
Market Cap
$621.68K
Enterprise Value$575.58K
Total Cash (Recent Filing)$654.34K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)56.7
Beta1.19
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding36,023,903
10 Day Avg. Volume1,115
30 Day Avg. Volume4,677
Standard Deviation0.39
R-Squared0.00005
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-71.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue-20.31
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda35.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Restart Life Sciences News
PremiumCompany Announcements
Nova Mentis Announces Share Consolidation and Name ChangePremiumCompany Announcements
Nova Mentis Appoints New CEO to Drive Growth
PremiumCompany Announcements
Nova Mentis Life Science Announces Strategic IP Deal
PremiumCompany Announcements
Nova Mentis Welcomes New Board MemberOptions Prices
Currently, No data available
---
Ownership Overview
NMLSF FAQ
What was Restart Life Sciences’s price range in the past 12 months?
Restart Life Sciences lowest stock price was $0.01 and its highest was $0.09 in the past 12 months.
What is Restart Life Sciences’s market cap?
Restart Life Sciences’s market cap is $621.68K.
When is Restart Life Sciences’s upcoming earnings report date?
Restart Life Sciences’s upcoming earnings report date is Apr 24, 2025 which is in 95 days.
How were Restart Life Sciences’s earnings last quarter?
Currently, no data Available
Is Restart Life Sciences overvalued?
According to Wall Street analysts Restart Life Sciences’s price is currently Overvalued.
Does Restart Life Sciences pay dividends?
Restart Life Sciences does not currently pay dividends.
What is Restart Life Sciences’s EPS estimate?
Restart Life Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Restart Life Sciences have?
Restart Life Sciences has 36,023,903 shares outstanding.
What happened to Restart Life Sciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Restart Life Sciences?
Currently, no hedge funds are holding shares in NMLSF
---
Company Description
Restart Life Sciences
Liberty Leaf Holdings Ltd. engages in building and supporting a diversified portfolio of cannabis-sector businesses. It offers cultivation, processing, value-added cannabidiol & pet products, and supply chain products. The company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
---
Technical Analysis
Relmada Therapeutics
―
Bioxcel Therapeutics
―
Anavex Life Sciences
―
Cybin
―
Mind Medicine
―
COMPASS Pathways
―
---